A detailed history of Toroso Investments, LLC transactions in United Therapeutics Corp stock. As of the latest transaction made, Toroso Investments, LLC holds 8,269 shares of UTHR stock, worth $2.63 Million. This represents 0.03% of its overall portfolio holdings.

Number of Shares
8,269
Previous 8,102 2.06%
Holding current value
$2.63 Million
Previous $1.78 Million 6.63%
% of portfolio
0.03%
Previous 0.04%

Shares

12 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

May 15, 2024

BUY
$210.76 - $249.51 $35,196 - $41,668
167 Added 2.06%
8,269 $1.9 Million
Q4 2023

Feb 14, 2024

BUY
$214.88 - $256.94 $153,854 - $183,969
716 Added 9.69%
8,102 $1.78 Million
Q3 2023

Nov 15, 2023

SELL
$211.82 - $248.24 $13,556 - $15,887
-64 Reduced 0.86%
7,386 $1.67 Million
Q2 2023

Aug 14, 2023

SELL
$205.19 - $232.99 $1.27 Million - $1.44 Million
-6,185 Reduced 45.36%
7,450 $1.65 Million
Q1 2023

May 15, 2023

BUY
$212.99 - $276.17 $905,846 - $1.17 Million
4,253 Added 45.33%
13,635 $3.05 Million
Q4 2022

Feb 15, 2023

BUY
$205.95 - $280.43 $175,881 - $239,487
854 Added 10.01%
9,382 $2.61 Million
Q3 2022

Nov 23, 2022

SELL
$203.3 - $244.17 $50,215 - $60,309
-247 Reduced 2.81%
8,528 $1.79 Million
Q2 2022

Aug 15, 2022

SELL
$174.81 - $241.14 $612,709 - $845,195
-3,505 Reduced 28.54%
8,775 $2.07 Million
Q1 2022

May 20, 2022

BUY
$166.16 - $213.96 $1.71 Million - $2.2 Million
10,272 Added 511.55%
12,280 $2.2 Million
Q4 2021

Feb 16, 2022

SELL
$184.32 - $216.08 $993,853 - $1.17 Million
-5,392 Reduced 72.86%
2,008 $433,000
Q3 2021

Nov 15, 2021

BUY
$179.86 - $214.88 $192,630 - $230,136
1,071 Added 16.92%
7,400 $1.37 Million
Q2 2021

Aug 13, 2021

BUY
$170.47 - $211.93 $1.08 Million - $1.34 Million
6,329 New
6,329 $1.14 Million

Others Institutions Holding UTHR

About UNITED THERAPEUTICS Corp


  • Ticker UTHR
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 45,516,300
  • Market Cap $14.5B
  • Description
  • United Therapeutics Corporation, a biotechnology company, engages in the development and commercialization of products to address the unmet medical needs of patients with chronic and life-threatening diseases in the United States and internationally. Its commercial therapies include Remodulin to treat patients with pulmonary arterial hypertensio...
More about UTHR
Track This Portfolio

Track Toroso Investments, LLC Portfolio

Follow Toroso Investments, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Toroso Investments, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Toroso Investments, LLC with notifications on news.